CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain

Overview of attention for article published in Molecular Therapy - Methods & Clinical Development, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 6 X users

patent: 8 patents

Readers on

mendeley: 341 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 10,731 followers.

https://t.co/u2v5CwueU1

"These results suggest the potential for AAV-PHP.eB as a vector for CNS gene therapy applications, but consideration will be required for translation beyond mouse models @Dr_RKarda @RickPrivolizzi @DrJo_Ng @ProfAhadRahim https://t.co/4bDH34Aebr

The authors of "CNS Transduction Benefits of AAV-PHP.eB over AAV9…" (https://t.co/LkcP1mHBdk) included RRIDs in their paper! We appreciate the author's support of reproducibility. #methodsmatter #reproducibility

CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain. https://t.co/F1PRqhwKDh https://t.co/Ond9pPhi1D

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.